EU nod for first long-acting HIV injectable treatment
Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed
22nd December 2020
Latest news
MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
22nd December 2020
AZ, Amgen’s SOURCE trial misses primary endpoint
New medicine tezepelumab is being studied in severe asthma
22nd December 2020
Pfizer, BioNTech win EU authorisation for COVID-19 vaccine Comirnaty
Follows positive opinion issued by EMA's CHMP
22nd December 2020
Roche’s faricimab hits the mark in diabetic macular edema study
Treatment demonstrated non-inferior visual acuity gains compared to Regeneron's Eylea
21st December 2020
Aimmune’s peanut allergy med Palforzia wins EU approval
Drug becomes first treatment for peanut allergy in the EU
21st December 2020
US approves Moderna’s COVID-19 vaccine for emergency use
Company will immediately begin delivering doses to the US government
21st December 2020
Green light for AZ’s Tagrisso in early-stage lung cancer
EGFR-TKI approved in the US for early non-small cell lung cancer
21st December 2020
Scancell picks lead COVID-19 vaccine candidate
SN14 will be advanced through further development and clinical trials
18th December 2020
GSK co-leads investment in ‘disease rebalancing’ Adrestia Therapeutics
British pharma company also announces strategic collaboration agreement
18th December 2020
Novo Nordisk eyes EU approval for once-weekly semaglutide
Danish pharma is seeking approval for drug as a weight management therapy
18th December 2020
NHS England invests £10m in network of ‘long COVID’ clinics
Specialist help will be available at 69 sites across the country
18th December 2020
PharmaTimes are excited to announce the launch of INTCR 2021
Flying the flag for excellence in global clinical research, the prestigious PharmaTimes International Clinical Researcher of the Year opens its doors for entry.
17th December 2020
EUSA Pharma launches phase III COVID-19 study for siltuximab
Study will enrol hospitalised COVID-19 patients with serious viral acute respiratory distress syndrome
17th December 2020
International consortium creates ‘open platform’ for COVID-19 drug discovery
Consortium is led by Cambridge Medical Research Council (MRC) researchers
17th December 2020
